Exploration and comparison of the effectiveness of swarm intelligence algorithm in early identification of cardiovascular disease - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39920227/
Due to the aging of the global population and lifestyle changes, cardiovascular disease has become the leading cause of death worldwide, causing serious public health problems and economic pressures. Early...
https://pubmed.ncbi.nlm.nih.gov/39920227/
Swarm intelligence-based feature selection improves early cardiovascular disease prediction by boosting machine learning model accuracy, with cuckoo and whale algorithms yielding optimal results on combined and Framingham datasets, respectively.
Cardiovascular risk in patients with osteoporosis within a Rheumatology setting. Results from a Spanish survey-based multicenter study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39894630/
Most patients with OP are women with primary OP, often having CVRF. Oral bisphosphonates, denosumab, and teriparatide are the preferred treatments, avoiding MHT, SERMs, and romosozumab in patients with CVRF.
The VASOS study found that osteoporosis patients, mostly women, often have cardiovascular risk factors, influencing treatment choices. Rheumatologists prefer bisphosphonates, denosumab, and teriparatide while avoiding MHT, SERMs, and romosozumab.
Mediation role of health behaviours in the relation between mental resilience and cardiovascular risk in young adults with a diagnosed congenital heart defect - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40065270/
Health-related behaviours play a mediation role between mental resilience and the cardiovascular risk in the group of young adults with congenital heart defects. Psychological resilience as a preventive and promotional...
Higher psychological resilience in young adults with congenital heart defects is linked to healthier behaviors, reducing cardiovascular risk. Health-promoting programs should incorporate resilience assessment to enhance patient care and prevention strategies.
The AHA/ACC statement provides clinical guidance on cardiovascular risks in athletes, outlining considerations for competitive sports participation, sudden cardiac arrest prevention, and shared decision-making based on expert-reviewed literature.
Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39976316/
This American Heart Association/American College of Cardiology scientific statement on clinical considerations for competitive sports participation for athletes with cardiovascular abnormalities or diseases is organized into 11 distinct sections focused...
Cardiovascular Effects of Antiseizure Medications for Epilepsy - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39951223/
Antiseizure medications (ASMs) are the primary treatment for epilepsy. However, adverse cardiac effects of ASMs can occur, related to their effects on lipid metabolism, raising ischemic heart disease risk; or...
Antiseizure medications (ASMs) can impact cardiovascular health by altering lipid metabolism and cardiac ion channels, increasing ischemic heart disease and arrhythmia risks. Monitoring and managing these effects are crucial for epilepsy patients.